The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMYRIS INC COM NEW 03236M200 4,000 292,398 SH   SOLE   292,398 0 0
ATRECA INC CL A COM 04965G109 8,700 1,396,644 SH   SOLE   1,396,644 0 0
BIONTECH SE SPONSORED ADS 09075V102 40,600 148,674 SH   SOLE   148,674 0 0
BUTTERFLY NETWORK INC CL A COM 124155102 10,600 1,011,003 SH   SOLE   1,011,003 0 0
CUREVAC N V COM N2451R105 171,200 3,134,780 SH   SOLE   3,134,780 0 0
IMMUNCORE HLDGS PLC ADS 45258D105 21,400 576,923 SH   SOLE   576,923 0 0
LUMIRADX LIMITED SHS G5709L109 46,100 5,574,059 SH   SOLE   5,574,059 0 0
SERA PROGNOSTICS INC CL A COM 81749D107 8,700 779,814 SH   SOLE   779,814 0 0
VIR BIOTECHNOLOGY INC COM 92764N102 29,500 677,777 SH   SOLE   677,777 0 0
ZYMERGEN INC COM 98985X100 800 59,970 SH   SOLE   59,970 0 0